1-3 of 3
Brian Clagett
Close
Sort by
Journal Articles

The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial

Clinical Trials & Observations
Peter W. Hunt, Nancy S. Shulman, Timothy L. Hayes, Viktor Dahl, Ma Somsouk, Nicholas T. Funderburg, Bridget McLaughlin, Alan L. Landay, Oluwatoyin Adeyemi, Lee E. Gilman, Brian Clagett, Benigno Rodriguez, Jeffrey N. Martin, Timothy W. Schacker, Barbara L. Shacklett, Sarah Palmer, Michael M. Lederman, Steven G. Deeks
Journal: Blood
Blood (2013) 121 (23): 4635–4646.
https://doi.org/10.1182/blood-2012-06-436345
Published: 2013
Includes: Supplemental data
Journal Articles

Response: absence of CCR5 intracellular pools in most CD4 and CD8 T cells

Heather A. Pilch-Cooper, Scott F. Sieg, Thomas J. Hope, Valentina Mercanti, Robin Offord, Ronald S. Veazey, Donald E. Mosier, Brian Clagett, Julie K. Jadlowsky, Mark R. Chance, Ronald G. Collman, Nadeene E. Riddick, Oliver Hartley, Michael M. Lederman
Journal: Blood
Blood (2011) 118 (4): 1179.
https://doi.org/10.1182/blood-2011-05-350231
Published: 2011
Journal Articles

Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5

Brief Report
Heather A. Pilch-Cooper, Scott F. Sieg, Thomas J. Hope, Ann Koons, Jean-Michel Escola, Robin Offord, Ronald S. Veazey, Donald E. Mosier, Brian Clagett, Kathy Medvik, Julie K. Jadlowsky, Mark R. Chance, Janna G. Kiselar, James A. Hoxie, Ronald G. Collman, Nadeene E. Riddick, Valentina Mercanti, Oliver Hartley, Michael M. Lederman
Journal: Blood
Blood (2011) 118 (4): 1015–1019.
https://doi.org/10.1182/blood-2010-05-282509
Published: 2011
Includes: Supplemental data